D. E. Shaw & Co., Inc. Amneal Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 89,895 shares of AMRX stock, worth $777,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,895

Previous 226,204 60.26%

Holding current value

$777,591

Previous $1.37 Million 58.39%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.36 - $7.11 $730,616 - $969,156	-136,309 Reduced 60.26%	89,895 $570,000
Q1 2024 May 15, 2024	SELL	$5.24 - $6.34 $2.3 Million - $2.79 Million	-439,832 Reduced 66.04%	226,204 $1.37 Million
Q4 2023 Feb 14, 2024	SELL	$3.36 - $6.21 $701,836 - $1.3 Million	-208,880 Reduced 23.87%	666,036 $4.04 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $697,424 - $1.16 Million	252,690 Added 40.61%	874,916 $3.69 Million
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $10,484 - $24,437	-7,883 Reduced 1.25%	622,226 $1.93 Million
Q1 2023 May 15, 2023	SELL	$1.27 - $2.7 $74,584 - $158,565	-58,728 Reduced 8.53%	630,109 $875,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $838,854 - $1.12 Million	427,987 Added 164.07%	688,837 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $145,284 - $260,361	71,923 Added 38.07%	260,850 $527,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $195,866 - $290,221	-65,072 Reduced 25.62%	188,927 $601,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $374,310 - $469,327	95,977 Added 60.74%	253,999 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $552,921 - $818,883	139,980 Added 775.86%	158,022 $757,000
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $77,761 - $101,756	18,042 New	18,042 $96,000
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $628,602 - $837,318	-122,774 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $581,948 - $906,072	122,774 New	122,774 $826,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $551,741 - $1.2 Million	-224,285 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $331,464 - $695,450	125,081 Added 126.08%	224,285 $1.08 Million
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $136,197 - $422,272	-59,475 Reduced 37.48%	99,204 $288,000
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $1.71 Million - $3.79 Million	-265,301 Reduced 62.57%	158,679 $1.14 Million
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $4.5 Million - $5.62 Million	-378,882 Reduced 47.19%	423,980 $6.01 Million
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $744,690 - $1.22 Million	56,890 Added 7.63%	802,862 $10.9 Million
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $4.03 Million - $5.97 Million	-246,020 Reduced 24.8%	745,972 $16.6 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $13.8 Million - $20 Million	991,992 New	991,992 $16.3 Million

Others Institutions Holding AMRX

# of Institutions

187

Shares Held

137M

Call Options Held

234K

Put Options Held

45.9K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.31B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account